In summary, chronic TFF3 treatment normalized olfactory bulbectomy induced depressive-like behaviors by the regulation of the BDNF-ERK-CREB pathway in the hippocampal CA3, a brain area crucial for depression. The gene discussed is BDNF; the disease is depressive symptom measurement.